Late-breaking science announced for TVT Connect
Virtual CRF meeting covering the latest in structural heart disease will take place June 18-28
NEW YORK – June 8, 2020 – The Cardiovascular Research Foundation (CRF) announced that TVT Connect will feature eight studies as Late-Breaking Clinical Science. They will be presented during episodes moderated by the editors of Circulation: Cardiovascular Interventions and JACC: Cardiovascular Interventions.
Each late-breaking science episode will host a live wrap-up and Q&A session afterwards. The full agenda is now available online: https:/
Saturday, June 20, 2020
LATE-BREAKING CLINICAL SCIENCE I
8:00 AM – 9:30 AM ET
Moderator: Sunil V. Rao
Discussants: J. Dawn Abbott, Subhash Banerjee, David J. Cohen
Real World Experience with The SAPIEN 3 Ultra: A Propensity Matched Analysis from the United States
Valve-In-Surgical Valve with SAPIEN 3 For TAVR: Propensity-Matched Analyses of Real-World Data
TAVR with Self-Expandable Supra Annular Valves for Failed Surgical Bioprostheses: Insights from the TVT Registry
TAVR using Supra Annular, Self-Expanding Valves in Low Risk Patients
Sunday, June 21, 2020
LATE-BREAKING CLINICAL SCIENCE II
8:00 AM – 9:30 AM ET
Moderator: David J. Moliterno
Discussants: Samir Kapadia, Julinda Mehilli
Functional Status and Outcomes After TMVr in HF and Secondary MR: The COAPT Trial
First Prospective RCT Assessing Incidence of Reduced Leaflet Motion and its Clinical Impact Following TAVR
SAPIEN 3 TAVR versus Surgery in Intermediate-Risk Patients: A Propensity Score Matched Analysis of 5-Year Outcomes
Incidence, Characteristics, Predictors, and Outcomes of Surgical Explantation After TAVR: A Population-Based, Nationally Representative Analysis
TVT Connect is practical course featuring the latest research and cutting-edge techniques for structural heart interventions. For more than 10 years, TVT has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures.
In addition to late-breaking clinical science, five series will be broadcast via three hours of daily programming over 10 days. Attendees can tune into scheduled programming at specific times each day or watch on-demand after the original broadcast. Each series will focus on transcatheter aortic valve replacement (TAVR), mitral interventions, tricuspid Interventions, left atrial appendage (LAA) closure, or patent foramen ovale (PFO) closure.
HOW TO REGISTER:
Media may apply for registration by emailing [email protected]
The Cardiovascular Research Foundation (CRF) is one of the world’s leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For nearly 30 years, CRF has helped pioneer medical advances and educated doctors on the latest treatments for heart disease. CRF is comprised of the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team. For more information, visit http://www.